Furthermore, PRR15 expression was much lower in TNBC cells than in MCF10A and less aggressive/metastatic luminal-like, together with HER2amp breast cancer cells, which was further validated using CCLE panel (Fig. 1f, g). This evidence concerns the gene PRR15 and breast carcinoma.